中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2008年
11期
1823-1824
,共2页
陈洁瑛%陈震宏%吴兴荣%周红梅
陳潔瑛%陳震宏%吳興榮%週紅梅
진길영%진진굉%오흥영%주홍매
复方去氧孕烯%子宫疾病
複方去氧孕烯%子宮疾病
복방거양잉희%자궁질병
Desogestrel%Uterine
目的 探讨复方去氧孕烯治疗子宫腺肌病的临床疗效.方法 对42例子宫腺肌病患者于月经第1天开始服用复方去氧孕烯片,每次1片,每日1次,连续21 d.停7 d后开始下一个周期,共6个周期.观察用药前后月经量、血红蛋白及子宫体积变化,采用视觉模糊评分法(VAS)进行痛经评分.结果 服用复方去氧孕烯治疗6个月后疼痛明显减轻,评分由原来(8.51±1.73)分降至(0.62±0.70)分,P<0.01;经量减少,血红蛋白治疗前为(104.71±12.09)g/L,治疗6个月后为(112.00±8.57)g/L,P<0.01;治疗6个月后子宫体积稍缩小,但不明显(P>0.05).结论 复方去氧孕烯治疗子宫腺肌病近期疗效显著,且价廉、方便.
目的 探討複方去氧孕烯治療子宮腺肌病的臨床療效.方法 對42例子宮腺肌病患者于月經第1天開始服用複方去氧孕烯片,每次1片,每日1次,連續21 d.停7 d後開始下一箇週期,共6箇週期.觀察用藥前後月經量、血紅蛋白及子宮體積變化,採用視覺模糊評分法(VAS)進行痛經評分.結果 服用複方去氧孕烯治療6箇月後疼痛明顯減輕,評分由原來(8.51±1.73)分降至(0.62±0.70)分,P<0.01;經量減少,血紅蛋白治療前為(104.71±12.09)g/L,治療6箇月後為(112.00±8.57)g/L,P<0.01;治療6箇月後子宮體積稍縮小,但不明顯(P>0.05).結論 複方去氧孕烯治療子宮腺肌病近期療效顯著,且價廉、方便.
목적 탐토복방거양잉희치료자궁선기병적림상료효.방법 대42례자궁선기병환자우월경제1천개시복용복방거양잉희편,매차1편,매일1차,련속21 d.정7 d후개시하일개주기,공6개주기.관찰용약전후월경량、혈홍단백급자궁체적변화,채용시각모호평분법(VAS)진행통경평분.결과 복용복방거양잉희치료6개월후동통명현감경,평분유원래(8.51±1.73)분강지(0.62±0.70)분,P<0.01;경량감소,혈홍단백치료전위(104.71±12.09)g/L,치료6개월후위(112.00±8.57)g/L,P<0.01;치료6개월후자궁체적초축소,단불명현(P>0.05).결론 복방거양잉희치료자궁선기병근기료효현저,차개렴、방편.
Objective To evaluate the efficacy of Marvelon on treatment of adenomyosis.Methods A total of 42 women with adenomyosis were recruited in the study.They were given Marvelon on the first day of menstruation,1 piece,qd,continouly for 21 days.With an alternation of seven days a new cycle begins.There are 6 cycles in total.We observe their degree of dysmenorrheal,menstrual blood volume(MBV) ,hemoglobin and the volume of uterus before and after Marvelon used.Results After 6 months,the dysmenorrheal remitted obviously,the score decline from (8.51±1.73 ) to (0.62±0.70) ,P <0.01.The MBV reduced and hemoglobin rise distinctly ,before treatment Hb is (104.71±12.09) while (112.00±8.57)after therapy,P <0.01.After treatment the volume of uterus shrinks a little, but not significant(P > 0.05).Conclusion Marvelon is an effective drug in treatment of adenomyosis in the near future,and is cheap,convcnieat.